[{"NetIncomeLoss_2_Q2_USD":-1000.0,"Assets_0_Q2_USD":236800.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":10000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":6000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":6000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromRelatedPartyDebt_2_Q2_USD":150000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":32121.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":7520000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":132879.0,"CostsAndExpenses_2_Q2_USD":1000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":32121.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"DeferredCosts_0_Q2_USD":204679.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":25000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":236800.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"NetIncomeLoss_1_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":71800.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":11.5,"CashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"AdditionalPaidInCapital_0_Q2_USD":24310.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_0_Q2_shares":1.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":32121.0,"LiabilitiesCurrent_0_Q2_USD":212800.0,"NotesPayableRelatedPartiesClassifiedCurrent_0_Q2_USD":140000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":32121.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1000.0,"StockholdersEquity_0_Q2_USD":24000.0,"ProfitLoss_2_Q2_USD":-1000.0,"ProceedsFromIssuanceOfWarrants_0_Q2_USD":7520000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1000.0,"Ticker":"GLS","CIK":"1805087","name":"CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.","OfficialName":"Gelesis Holdings Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"341682749.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NYSE","SP500":"nan","filed":"20200817"}]